Abstract
The hepatitis D virus (HDV) infection plays a major role in severe liver damage caused by hepatitis. To establish the prevalence of HDV infection in haemophilic patients and patients without haemophilia, 87 patients with chronic hepatitis B virus (HBV) infection were examined for serological evidence of delta hepatitis. In addition HBV, HDV and human immunodeficiency virus type 1 (HIV) infection markers were compared to clinical and histopathological outcome of hepatitis. Out of 46 haemophiliacs 30 (65%) were anti-HD-seropositive; 10 out of 30 anti-HD-positive patients (33%) had pathological liver function tests compared to 2 out of 16 anti-HD-negative haemophiliacs (13%). The rate of HIV infection did not differ between the HDV infected and the non-HDV infected individuals with haemophilia (17/27 anti-HD-positive patients versus 12/16 anti-HD-negative patients). Two haemophilic anti-HD-positive patients underwent liver biopsy, in both cases hepatitis D antigen (HDAg) was detected in the biopsies. Only 2 out of 41 patients without haemophilia were anti-HD-positive. Both had pathological liver function tests; chronic active hepatitis and cirrhosis, respectively, were diagnosed and HDAg was found in the liver biopsies. Out of 39 anti-HD-seronegative patients without haemophilia, 26 (67%) were hepatitis B e antigen positive; in the sera of 20 patients )51%) HBV-DNA was demonstrated, but only 6 patients (15%) had pathological liver function tests. In conclusion a high seroprevalence of HDV infection was found in haemophilic patients treated with non-pasteurized commercial clotting factor concentrates. An endemic spreading of HDV infection in patients without haemophilia with chronic HBV infection could not be detected. In haemophilic patients pathological liver function tests were more frequently associated with HDV superinfection than with chronic HBV infection alone. HIV infection was diagnosed at a similar rate in anti-HD-positive and anti-HD-negative patients.
Similar content being viewed by others
Abbreviations
- Anti-HBe:
-
antibody to HBeAg
- Anti-HBs:
-
antibody to HBsAg
- Anti-HD:
-
antibody to hepatitis D antigen
- HBeAg:
-
hepatitis B e antigen
- HBsAg:
-
hepatitis B surface antigen
- HBV:
-
hepatitis B virus
- HDAg:
-
hepatitis D antigen
- HDV:
-
hepatitis D virus
- HIV 1:
-
human immunodeficiency virus type 1
References
Amoroso P, Giorgio A, Fico P et al (1986) Delta infection in the Naples area J Hepatol 2:11–18
Barre-Sinoussi F, Cherman JC, Rey F et al (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for aquired immune deficiency syndrome (AIDS) Science 220:868–871
Bonino F, Rossina F, Rizetto M, Rizzi R, Chiaberge E, Tardanico R, Callea F, Verme G (1986) Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe. Gastroenterology 90:1268–1273
Cuthbert JA (1985) Hepatitis D II. Experimental and clinical studies of Delta agent, the hepatitis D virus. Surv Dig Dis 3:1–11
DiBisceglie AM, Negro F (1989) Diagnosis of hepatitis delta virus infection. Heptalogy 10 No 6:1014–1016
Dienes HP, Purcell RH, Popper H, Ponzetto A (1990) The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees. J Hepatol 10: 77–84
Drake JH, Pamley RT, Britton HA (1987) Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients. Pediatr Infect Dis J 6:1051–1054
Gallo RC, Salahuddin SZ, Popovic M et al (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500–502
Gilson RJC, Tedder RS, Weller IVD (1989) Hepatitis B: Reactivation or reinfection associated with HIV-1 infection. Lancet I:1330
Gmelin K, Theilmann L, Kommerell B, Roggendorf M, Deinhardt F (1986) Hepatitis-Delta-Virus-Infektion: Pathogenese, Klinik und Epidemiologie. Dtsch Ärzteblatt 51/52:3607–3612
Govindarajan S, Valinluck B, Peters RC (1986) Relapse of acute B Viral hepatitis — role of Delta agent. Gut 27:19–22
Hsu HY, Chang MJ, Chen DS, Lee CY (1988) Hepatitis D virus infection with acute or chronic hepatitis B virus infection in Taiwan. J Pediatr 112, 6:888–892
Inagati M, Miura T, Taki M, Saito N, Yamada K, Unuma T, Tsuda F, Miyakawa Y, Mayumi M (1988) Infection with hepatitis delta and human immunodeficiency viruses among hemophiliacs in Japan. Transfusion 28, 1:18–20
Koff RS (1987) Fulminant hepatitis due to HBV/HDV Coinfection. Hosp Pract: 123–150
Krogsgaard K, Aldershvile J, Kryger P et al (1985) Hepatitis B virus DNA, HBeAG and delta infection during the course from acute to chronic hepatitis B virus infection. Hepatology 5:778–782
Krogsgaard K, Lindhardt BÖ, Nielsen JO, Andersson P, Kryger P, Aldersvhille J, Gerstoft J, Pedersen C (1987) The influence of HTLV III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 7:37–41
Krogsgaard K, Kryger P, Aldersvhille J, Andersson P, Sörensen TJA, Nielsen JO (1987) Delta infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. Hepatology 7:42–45
Lettau LA, McCarthy IG, Smith MH et al (1987) Outbreak of severe hepatitis due to Delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 317:1256–1262
Lin HH, Liaw YF, Chen TJ, Chu CM, Huang MJ (1989) Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection. Liver 9:129–134
Lok ASF, Lindsay I, Scheuer PJ, Thomas HC (1985) Clinical and histological features of delta infection in chronic hepatitis B virus carriers. J Clin Path 38:530–533
Maggiore G, Hadchouel M, Sessa F, Vinci M, Craxi A, Marzani MD, DeGiacomo C, Alagille D (1985) A retrospective study of the role of Delta agent infection in children with HBsAg positive chronic hepatitis. Hepatology 5 No 1:7–9
Morante AL, DeLA Cruz F, DeLope CR, Echevarria S, Rodriguez GM, Pons-Romero F (1989) Hepatitis B virus replication in hepatitis B and D coinfection. Liver 9:65–70
Novick DM, Farci P, Croxson TS, Taylor MB, Schneebaum CW, Lai ME, Bach N, Senie RE, Gelb AM, Kreek MJ (1988) Hepatitis D virus and HIV antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 158:7950803
Pastore G, Santantonio T, Monno L, Milella M, Luchena N, Angarano G (1988) Effects of HIV superinfection on HBV replication in a chronic HBsAg carrier with liver disease. J Hepatol 7:164–168
Rizetto M, Canese MG, Arico' S, Crivelli O, Tropo C, Bonino F, Verme G (1977) Immunofluorescence detection of a new antigen-antibody system (delta anti-delta) associated to hepatitis B virus in liver and serum of HBsAg carriers. Gut 18:997–1003
Rizetto M, Hoyer B, Canese MG, Shih JWK, Purcell RH, Gerin JC (1980) Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci USA 77:6124–6128
Rizetto M, Ponzetto M, Marinucci G (1988) Transfusion-related delta hepatitis. Transf Med Rev 2, 4:224–228
Roggendorf M, Gmelin K, Zoulek G, Wolf G, Schlipköter U, Jilg W, Theilmann L, Deinhardt F (1986) Epidemiological studies on the prevalence of hepatitis delta virus infections in the Federal Republic of Germany. J Hepatol 2:230–236
Schimpf K (1988) Clinical studies on virus-inactivated coagulation factor concentrates (abstract) XVIII International Congress of the world federation of hemophilia, Madrid, no 358
Shattock AG, Finlay H, Hillary JB (1987) Possible reactivation of hepatitis D with chronic Delta antigenaemia by human immunodeficiency virus. BMJ 293:1656–1657
Solomon RE, Kaslow RA, Phair JB, Lyter D, Visscher B, Lyman D, Vanvaden MT, Gerin J (1988) HIV and Hepatitis Delta Virus in homosexual men. Ann Int Med 108:51–54
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wagner, N., Rotthauwe, H.W., Becker, M. et al. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis. Eur J Pediatr 151, 90–94 (1992). https://doi.org/10.1007/BF01958949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01958949